3-imidazol-1-yl-N-[(5-methylfuran-2-yl)methyl]-N-[(5-thiophen-2-yl-1H-pyrazol-4-yl)methyl]propan-1-amine
C20H23N5OS — CID 16676756
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-imidazol-1-yl-N-[(5-methylfuran-2-yl)methyl]-N-[(5-thiophen-2-yl-1H-pyrazol-4-yl)methyl]propan-1-amine
3-imidazol-1-yl-N-[(5-methylfuran-2-yl)methyl]-N-[(5-thiophen-2-yl-1H-pyrazol-4-yl)methyl]propan-1-amine (PubChem CID 16676756) has the molecular formula C20H23N5OS and a molecular weight of 381.51 g/mol. Its IUPAC name is 3-imidazol-1-yl-N-[(5-methylfuran-2-yl)methyl]-N-[(5-thiophen-2-yl-1H-pyrazol-4-yl)methyl]propan-1-amine.
Molecular Properties
| Compound Name | 3-imidazol-1-yl-N-[(5-methylfuran-2-yl)methyl]-N-[(5-thiophen-2-yl-1H-pyrazol-4-yl)methyl]propan-1-amine |
|---|---|
| PubChem CID | 16676756 |
| Molecular Formula | C20H23N5OS |
| Molecular Weight | 381.51 g/mol |
| Exact Mass | 381.16 |
| IUPAC Name | 3-imidazol-1-yl-N-[(5-methylfuran-2-yl)methyl]-N-[(5-thiophen-2-yl-1H-pyrazol-4-yl)methyl]propan-1-amine |
| SMILES | Cc1ccc(CN(CCCn2ccnc2)Cc2cn[nH]c2-c2cccs2)o1 |
| InChI | InChI=1S/C20H23N5OS/c1-16-5-6-18(26-16)14-25(9-3-8-24-10-7-21-15-24)13-17-12-22-23-20(17)19-4-2-11-27-19/h2,4-7,10-12,15H,3,8-9,13-14H2,1H3,(H,22,23) |
| InChIKey | RFTYFZNJNZJFRJ-UHFFFAOYSA-N |
| XLogP | 4.33 |
| TPSA | 62.88 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 381.51 |
| LogP ≤ 5 | 4.33 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 16676756 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.